TITLE

Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial

AUTHOR(S)
Chiu P W Y; Lam C Y W; Lee S W; Kwong K H; Lam S H; Lee D T Y; Kwok S P Y
PUB. DATE
October 2003
SOURCE
Gut;Oct2003, Vol. 52 Issue 10, p1403
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: Recurrent bleeding after initial haemostasis is an important factor that directly relates to the outcome in the management of peptic ulcer bleeding. Conflicting reports have been published concerning the effectiveness of scheduled second therapeutic endoscopy on ulcer rebleeding. We investigate the use of scheduled second endoscopy with appropriate therapy on peptic ulcer rebleeding. METHODS: From August 1999 to January 2001, we prospectively randomised patients who had endoscopically confirmed bleeding peptic ulcer with stigmata of acute bleeding, visible vessel, or adherent clot into two groups. Endoscopic therapy was standardised to initial epinephrine injection and subsequent heater probe application. The study group (n = 100) received scheduled second endoscopy 16-24 hours after initial haemostasis, and further therapy was applied if endoscopic stigmata persisted, as above. The control group (n = 94) were observed closely. Those patients that developed rebleeding in either group underwent operation if further endoscopic therapy failed. Outcome measures included ulcer rebleeding, transfusion, duration of stay, and mortality. RESULTS: After initial endoscopic haemostasis, 194 eligible patients were randomised into two groups. Thirteen patients in the control group developed recurrent bleeding within 30 days while five patients in the study group sustained recurrent bleeding (p = 0.0314) (relative risks 0.33, 95% confidence interval 0.1-0.96). The number of patients that required surgery for recurrent bleeding was six in the control group and one in the study group (p = 0.05). There was no difference in duration of hospital stay, transfusion, or mortality between the two groups. CONCLUSIONS: A scheduled repeat endoscopy with appropriate therapy 16-24 hours after initial endoscopic haemostasis reduces the number of cases of recurrent bleeding.
ACCESSION #
10854350

 

Related Articles

  • A Prospectively Randomized Trial of Heat Probe Thermocoagulation versus Pure Alcohol Injection in Nonvariceal Peptic Ulcer Hemorrhage. Lin, Hwai J.; Tsai, Yang T.; Lee, Shou D.; Lai, Kwok H.; Lee, F. Y.; Lin, Ching Y.; Lee, Chen H. // American Journal of Gastroenterology;Mar1988, Vol. 83 Issue 3, p283 

    We conducted a prospectively randomized trial of 78 patients with peptic ulcer hemorrhage to evaluate the hemostatic effects of heat probe thermocoagulation and pure alcohol injection. The initial and ultimate success rates of heat probe thermocoagulation were better than those of pure alcohol...

  • Long-term Follow-up of Endoscopic Treatment for Bleeding Gastric and Duodenal Ulcers. Inadomi, John; Koch, Johannes; Cello, John P. // American Journal of Gastroenterology;Jul1995, Vol. 90 Issue 7, p1065 

    Objective: To examine the long-term consequences of endoscopic therapy for bleeding peptic ulcers. Methods: Eighty-seven consecutive patients who underwent endoscopic treatment for bleeding gastric ulcer (GU) and/or duodenal ulcer (DU) over a 42-month period were identified. Long-term follow-up...

  • A scheduled second endoscopy 16 to 24 hours after initial endoscopic hemostasis reduced recurrent peptic ulcer bleeding: COMMENTARY. Howden, Colin W. // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p11 

    This article focuses on a study regarding the effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding, published in the 2003 issue of the journal "Gut." In the author's opinion, only a few patients with ulcer bleeding might benefit from a planned second therapeutic endoscopy....

  • Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Rockall, T. A. // Journal of the Royal Society of Medicine;Oct1998, Vol. 91 Issue 10, p518 

    Most patients with acute upper gastrointestinal haemorrhage are managed conservatively or with endoscopic intervention but some ultimately require surgery to arrest the haemorrhage. We have conducted a population-based multicentre prospective observational study of management and outcomes. This...

  • Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy. Kim, Sung; Lee, Si; Kim, Kyeong; Jang, Byung; Kim, Tae; Jeon, Seong; Kwon, Joong; Kim, Eun; Jung, Jin; Park, Kyung; Cho, Kwang; Kim, Hyun; Park, Chang; Park, Jeong; Yang, Chang; Kim, Sung Bum; Lee, Si Hyung; Kim, Kyeong Ok; Jang, Byung Ik; Kim, Tae Nyeun // Digestive Diseases & Sciences;Feb2016, Vol. 61 Issue 2, p517 

    Background: Re-bleeding after initial hemostasis in peptic ulcer bleeding can be life threatening. Identification of factors associated with re-bleeding is important. The aims of this study were to determine incidence of rebleeding in patients with high risk peptic ulcer bleeding...

  • When living on adrenaline isn't enough.  // Gut;Sep2006, Vol. 55 Issue 9, p1340 

    The article presents information on a study that compared the efficacy of combination therapy and epinephrine alone in the treatment of patients suffering from peptic ulcer bleeding. The measures for rating the outcome of the two treatments were rates of initial haemostasis and recurrent...

  • High-dose pantoprazole cost effective in bleeding peptic ulcer.  // PharmacoEconomics & Outcomes News;3/13/2004, Issue 448, p7 

    Discusses research being done on the treatment of patients with bleeding peptic ulcers following successful endoscopic haemostasis. Reference to a study by A. N. Barkun and colleagues published in a March 2004 issue of "Alimentary Pharmacology and Therapeutics"; Assessment of costs and...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • Surgical therapy for peptic ulcer and nonvariceal bleeding. Schoenberg, M. H. // Langenbeck's Archives of Surgery;Apr2001, Vol. 386 Issue 2, p98 

    Wider use of endoscopic hemostasis in upper gastrointestinal bleeding (UGIB) has reduced significantly the need for operation. Nevertheless, surgery still plays a pivotal role. Failure to control bleeding endoscopically should not delay surgery when necessary, and a close cooperation between...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics